ANGELA KAPALKO: Open Payments
NPI 1730376872 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,859 in 86 payments from 9 companies in 2025. Trend: 2023 $27,348 · 2024 $29,814 · 2025 $29,859
Speaker / faculty: $20,095Travel & lodging: $5,077Food & beverage: $2,437Honoraria: $1,575Consulting: $675
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 30 | $12,328 |
| ViiV Healthcare Company | 37 | $12,229 |
| Alkermes, Inc. | 4 | $2,962 |
| Theratechnologies Inc. | 2 | $1,644 |
| Merck Sharp & Dohme LLC | 5 | $522 |
| ABBVIE INC. | 4 | $88 |
| Exact Sciences Corporation | 2 | $34 |
| Lilly USA, LLC | 1 | $33 |
| Braeburn Inc. | 1 | $20 |
Products named: CABENUVA, Epclusa, Biktarvy, VIVITROL, EGRIFTA, APRETUDE, PIFELTRO, MAVYRET.
Industry payments across PA — which companies pay providers there.
